This paper is an example of nasal administration of a delivery-enabled Morpholino in mice.
Soonthornvacharin S, Rodriguez-Frandsen A, Zhou Y, Galvez F, Huffmaster NJ, Tripathi S, Balasubramaniam VRMT, Inoue A, de Castro E, Moulton H, Stein DA, Sánchez-Aparicio MT, De Jesus PD, Nguyen Q, König R, Krogan NJ, García-Sastre A, Yoh SM, Chanda SK. Systems-based analysis of RIG-I-dependent signalling identifies KHSRP as an inhibitor of RIG-I receptor activation. Nat Microbio. 2017;2:17022. doi:10.1038/nmicrobiol.2017.22
http://www.nature.com/articles/nmicrobiol201722\
"Mice were anaesthetized ... and inoculated via the intranasal route (i.n.) with the indicated 100 μg of PPMOs or PR8 influenza virus (500 plaque-forming units (p.f.u.)) in 40 μl PBS."
Add new comment